000			01934 a2200493 4500
005			20250513090731.0
264		0	_c19960701
008			199607s 0 0 eng d
022			_a1073-449X
024	7		_a10.1164/ajrccm.153.5.8630591 _2doi
040			_aNLM _beng _cNLM
100	1		_aRoux, F J
245	0	0	_aFunctional and binding characteristics of long-acting beta 2-agonists in lung and heart. _h[electronic resource]
260			_bAmerican journal of respiratory and critical care medicine _cMay 1996
300			_a1489-95 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdrenergic beta-Agonists _xadministration & dosage
650	0	4	_aAlbuterol _xadministration & dosage
650	0	4	_aAminophylline _xpharmacology
650	0	4	_aAnimals
650	0	4	_aBinding, Competitive _xdrug effects
650	0	4	_aBronchoconstriction _xdrug effects
650	0	4	_aBronchodilator Agents _xadministration & dosage
650	0	4	_aEthanolamines _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFenoterol _xpharmacology
650	0	4	_aFormoterol Fumarate
650	0	4	_aGuanine Nucleotides _xpharmacology
650	0	4	_aGuinea Pigs
650	0	4	_aHeart _xdrug effects
650	0	4	_aIodine Radioisotopes
650	0	4	_aIodocyanopindolol
650	0	4	_aIsoproterenol _xpharmacology
650	0	4	_aLung _xdrug effects
650	0	4	_aPindolol _xanalogs & derivatives
650	0	4	_aReceptors, Adrenergic, beta-1 _xmetabolism
650	0	4	_aReceptors, Adrenergic, beta-2 _xmetabolism
650	0	4	_aSalmeterol Xinafoate
650	0	4	_aTrachea _xdrug effects
700	1		_aGrandordy, B
700	1		_aDouglas, J S
773	0		_tAmerican journal of respiratory and critical care medicine _gvol. 153 _gno. 5 _gp. 1489-95
856	4	0	_uhttps://doi.org/10.1164/ajrccm.153.5.8630591 _zAvailable from publisher's website
999			_c8629630 _d8629630